FDA’s medication errors director to retire
Executive Summary
FDA Office of Drug Safety Medication Errors Prevention Associate Director Jerry Phillips is leaving to become president of the Drug Safety Institute. Phillips' May departure will likely coincide with the anticipated release of a guidance on submission of proprietary brand names (1"The Pink Sheet" Dec. 8, 2003, p. 35)...